Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress
Hiroki Kitakata, Jin Endo, Shun Hashimoto, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 572, pp. 185-190
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 22
Sex differences in heart mitochondria regulate diastolic dysfunction
Yang Cao, Laurent Vergnes, Yu-Chen Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Ferroptosis in heart failure
Xinquan Yang, Nicholas K. Kawasaki, Junxia Min, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 173, pp. 141-153
Open Access | Times Cited: 65
Short‐Term Oral Administration of the Porcupine Inhibitor, Wnt‐c59, Improves the Structural and Functional Features of Experimental HFpEF
Margaret Lorraine Paul, Cherry L. Wainwright, Emma E. Hector, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases
Ziyi Wang, Chao Wu, Dong Yin, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
Junpei Sanada, Atsushi Obata, Yoshiro Fushimi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation
Lili Zhang, Gui-hao Chen, Ruijie Tang, et al.
Cardiovascular Drugs and Therapy (2023) Vol. 38, Iss. 4, pp. 705-718
Open Access | Times Cited: 20
Ferroptosis in cardiac hypertrophy and heart failure
K. Zhang, Xin-Miao Tian, Wei Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115765-115765
Open Access | Times Cited: 19
Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways
Awaguli Dawuti, Shuchan Sun, Ranran Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115837-115837
Open Access | Times Cited: 17
iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation
Yongzheng Guo, Junjie Wen, An He, et al.
Journal of Advanced Research (2022) Vol. 43, pp. 175-186
Open Access | Times Cited: 25
Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach
Ali A. Alamer, Nasser B. Alsaleh, Alhassan H. Aodah, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1208-1208
Open Access | Times Cited: 15
Exploring new mechanisms of Imeglimin in diabetes treatment: Amelioration of mitochondrial dysfunction
Yilin Li, N. Lou, Xiaojing Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116755-116755
Open Access | Times Cited: 5
Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction
Qing Li, Zhiqiang Zhao, Xia Zhou, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2842-2842
Open Access | Times Cited: 20
Protective Effects of Imeglimin and Metformin Combination Therapy on β-Cells in db/db Male Mice
Kuniyuki Nishiyama, Masato Ono, Takahiro Tsuno, et al.
Endocrinology (2023) Vol. 164, Iss. 8
Open Access | Times Cited: 12
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 726-726
Open Access | Times Cited: 11
Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future
Ying Jie Chee, Rinkoo Dalan
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1386-1386
Open Access | Times Cited: 4
A look at MERCs as UPRmt regulatory hubs in age-associated heart diseases
Gabriela Navarrete-Anastasio, Zeltzin Alejandra Ceja-Galicia, Cecilia Zazueta, et al.
The Journal of Cardiovascular Aging (2025) Vol. 5, Iss. 1
Open Access
Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
Ruoxuan Ni, Jianwei Jiang, Fudi Wang, et al.
Science China Life Sciences (2025)
Closed Access
Ubiquitin ligase CHIP regulates neurological functional recovery after intracerebral hemorrhage through ubiquitination modification of FOXO1
Shuyang Wei, Zhizhu Peng, Zhongyi Zhang
Molecular & Cellular Toxicology (2025)
Closed Access
The roles of sirtuins in ferroptosis
Jieqing Zeng, Junhao Guo, Si Huang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 10
Efficacy and safety of imeglimin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials
Ibrahim Abdelmonaem Abdelhaleem, Hazem Mohamed Salamah, Feras Ammar Alsabbagh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 6, pp. 102323-102323
Closed Access | Times Cited: 23
ER stress and calcium-dependent arrhythmias
Shanna Hamilton, Dmitry Terentyev
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 15
A panoramic view of ferroptosis in cardiovascular disease
Xihao Cheng, Chao Yu, Xinquan Yang, et al.
Kidney Diseases (2023) Vol. 9, Iss. 3, pp. 173-186
Open Access | Times Cited: 9
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials
Katsuhiko Hagi, Masahiro Nitta, Hirotaka Watada, et al.
Journal of Diabetes Investigation (2023) Vol. 14, Iss. 11, pp. 1246-1261
Open Access | Times Cited: 9
Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats
Alex Smith, Raffaele Altara, Ghadir Amin, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 15
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top